Proteoglycan IMPG2 Shapes the Interphotoreceptor Matrix and Modulates Vision

Area of Science:

• Ophthalmology and Vision Science
• Cell Biology
• Extracellular Matrix Biology

Background:

• The interphotoreceptor matrix (IPM) is crucial for vision, supporting photoreceptor function and retinal integrity.
• Mutations in IPM proteoglycans (IMPG1, IMPG2) are linked to human visual deficits and subretinal material accumulation.
• Understanding IPM proteoglycan roles is vital for addressing vision loss pathologies.

Purpose of the Study:

• To investigate the distinct roles of IPM proteoglycan 1 (IMPG1) and IMPG2 in retinal physiology.
• To elucidate the pathological mechanisms underlying vision loss associated with IMPG1/IMPG2 dysfunction.
• To generate and analyze mouse models deficient in IMPG1 and/or IMPG2.

Main Methods:

• Generation and phenotypic analysis of IMPG1- and IMPG2-deficient mouse models.
• Assessment of retinal structure and function using morphological and electrophysiological techniques.
• Immunohistochemical analysis to determine proteoglycan localization and IPM composition.

Main Results:

• IMPG1 and IMPG2 occupy distinct IPM compartments and are the primary sources of chondroitin sulfate.
• Mice lacking IMPG1 showed no significant morphological or functional deficits.
• Absence of IMPG2 led to abnormal IPMG1 accumulation in the subretinal space, causing visual impairment and lesions.
• Mice lacking both IMPG1 and IMPG2 exhibited normal retinal structure and function, highlighting aberrant IMPG1 distribution as the key issue.

Conclusions:

• IMPG2 is essential for the proper integration of IMPG1 into the IPM, influencing IPM structure.
• Aberrant IMPG1 distribution, rather than its mere absence, drives the visual deficits observed in IMPG2-deficient retinas.
• These findings offer insights into subretinal lesion formation and provide potential targets for therapeutic interventions in IMPG-related visual disorders.